This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Hideo Miyao: Innovator in Nucleic Acid Delivery Systems
Introduction
Hideo Miyao is a prominent inventor based in Tokushima, Japan. He is known for his significant contributions to the field of nucleic acid delivery systems. His innovative work focuses on creating carrier compositions that enhance the efficiency and safety of nucleic acid transport.
Latest Patents
Miyao holds a patent for a "Carrier composition for nucleic acid transport." The objective of this invention is to provide a nucleic acid delivery carrier composition that exhibits low toxicity and high safety. This carrier composition is designed to efficiently deliver nucleic acids, such as siRNA, into animal-derived cells or organisms while protecting them from degradation. The composition is prepared by mixing a cationic lipid with a steroid skeleton and a tertiary ammonium salt-type cationic lipid.
Career Highlights
Hideo Miyao is associated with Otsuka Pharmaceutical Company, Limited, where he has made significant strides in the development of innovative pharmaceutical solutions. His work has been instrumental in advancing the field of gene therapy and nucleic acid delivery.
Collaborations
Miyao has collaborated with notable colleagues, including Kazuo Sekiguchi and Hidekazu Toyobuku. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.
Conclusion
Hideo Miyao's contributions to nucleic acid delivery systems highlight his role as an innovator in the pharmaceutical field. His work continues to pave the way for advancements in safe and effective gene therapy solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
